Deep Apple Therapeutics Raises $52M to Pioneer AI-Powered Drug Discovery

Deep Apple Therapeutics focuses on discovering novel therapeutics for high-value targets, utilizing ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries.

Source: deep apple

Company Name: Deep Apple Therapeutics
Location: San Francisco, CA
Sector: Biotechnology/Pharmaceuticals
Funding Details: Series A funding of $52M

Investors: The round was led by Apple Tree Partners
Purpose of Investment: Expansion of operations and advancement of development efforts

Leadership: Spiros Liras, Ph.D., Founding CEO
Product: An AI-driven discovery engine for novel small molecule therapeutics
About Company: Deep Apple Therapeutics focuses on discovering novel therapeutics for high-value targets, utilizing ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries. The company's approach expedites the process from target identification to lead optimization, primarily focusing on integral membrane proteins.

Writer Secures $200M in Series C Funding to Expand Generative AI Platform for Enterprises

Writer’s generative AI platform deploys AI applications and agents that address mission-critical challenges for businesses.

Shiru Raises $16M to Accelerate AI-Powered Ingredient Discovery

Shiru specializes in AI-powered discovery of functional ingredients derived from plants and microbes.

Alison.ai Secures $13.3M in Seed Funding to Drive Creative AI Solutions in Advertising

Alison.ai provides advertisers with a creative AI platform that eliminates the traditional iterative testing and experimentation process.

Read next